stimulants

You Asked: In a Woman with ADHD, Should You Continue Treatment with a Stimulant During the Postpartum Period?

A growing body of literature supports the reproductive safety of stimulants in pregnant women and suggests that not treating may have negative consequences for the mother and her child.

By |2024-06-26T12:48:46-04:00May 21st, 2024|ADHD, ADHD Medications, Medication, Postpartum Psychiatric Disorders, Treatment, You Asked|Comments Off on You Asked: In a Woman with ADHD, Should You Continue Treatment with a Stimulant During the Postpartum Period?

Neurodevelopmental Outcomes in Infants Exposed During Pregnancy to ADHD Medications

Prenatal exposure to ADHD medications, mostly methylphenidate, was not associated with an increased risk of neurodevelopmental disorders or growth restriction in exposed children.

By |2023-10-03T12:00:00-04:00October 11th, 2023|ADHD Medications, Neurodevelopmental Disorders, Outcomes, Pregnancy & Medications|Comments Off on Neurodevelopmental Outcomes in Infants Exposed During Pregnancy to ADHD Medications

New Research from the CWMH: The Course of ADHD During Pregnancy

We continue to see an increasing number of women with attention-deficit/hyperactivity disorder (ADHD) who are either pregnant or planning to conceive.  While we have considerable data to indicate that women with mood and anxiety [...]

By |2020-12-21T12:15:49-04:00December 22nd, 2020|ADHD, Prevalence & Risk Factors, Psychiatric Disorders During Pregnancy, Research at CWMH|Comments Off on New Research from the CWMH: The Course of ADHD During Pregnancy

Good News: More Data on the Use of ADHD Medications During Pregnancy

For women with mild to moderate attention-deficit/hyperactivity disorder (ADHD) symptoms, we often recommend discontinuing stimulant medications and switching to a non-pharmacologic intervention.  Many women experience some decrease in their level of functioning; however, they are [...]

By |2019-10-15T15:57:57-04:00December 22nd, 2017|ADHD Medications, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Good News: More Data on the Use of ADHD Medications During Pregnancy

Stimulants In Pregnancy and Increased Risk of Gestational Hypertension

  Our group has noted that we are seeing an increase in the number of consultations for women treated with psychostimulants in combination with an antidepressant.  The reasons vary.  Some women have depression and comorbid [...]

By |2020-11-26T08:30:35-04:00March 20th, 2017|Pregnancy & Medications|Comments Off on Stimulants In Pregnancy and Increased Risk of Gestational Hypertension

Clinical Update 2014: Use of Methylphenidate During Pregnancy

For women with mild to moderate attention-deficit/hyperactivity disorder (ADHD) symptoms, we frequently recommend discontinuing medication and switching to a non-pharmacologic intervention.  Although these women might experience some decrease in their level of functioning, they typically [...]

By |2017-12-22T14:40:20-04:00March 19th, 2014|ADHD Medications, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Clinical Update 2014: Use of Methylphenidate During Pregnancy

Clinical Update 2010: Use of Stimulant Medications in Pregnancy

Approximately 4% of the adult population suffers from ADHD. Attention and executive functioning difficulties also occur in those with mood and psychotic disorders and require treatment strategies similar to those used to address ADHD symptoms. First line medications most often used to treat ADHD in adults are Dextroamphetamine (Dexedrine, Adderall) and Methylphenidate (Concerta, Ritalin, Metadate).

By |2017-12-22T13:05:25-04:00September 27th, 2010|ADHD Medications, Outcomes, Pregnancy & Medications|Comments Off on Clinical Update 2010: Use of Stimulant Medications in Pregnancy
Go to Top